GT Biopharma, Inc. (GTBP)
0.5389
+0.04
(+8.54%)
USD |
NASDAQ |
Feb 06, 16:00
0.5035
-0.04
(-6.57%)
Pre-Market: 08:04
GT Biopharma Total Liabilities (Quarterly) : 1.321M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 5.925M |
| Lyell Immunopharma, Inc. | 78.84M |
| Geron Corp. | 318.68M |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Crinetics Pharmaceuticals, Inc. | 123.86M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.321M |
| Shareholders Equity (Quarterly) | 3.00M |
| Current Ratio | 2.696 |